We have been using QALYS since I was 18 since it was vigorously defended by Alan Williams In late March, the House Committee on Energy and Commerce made significant strides …
-
-
The journey from drug discovery to market approval is complex and time-consuming, often taking over a decade and billions of dollars. In response to the urgent need for treatments addressing …
-
The realm of orphan medicines, dedicated to addressing rare diseases affecting a fraction of the population, stands at a crossroads marked by regulatory gaps and uncertainties. As stakeholders navigate this …
-
In the realm of neuroradiology and neurology, a groundbreaking shift has emerged with the introduction of new CPT codes, 0865T and 0866T, by icometrix. These codes herald a transformative era, …
-
A decade ago, a surge of companies emerged with the promise of revolutionizing personal health through data tracking of habits like eating, sleep, and exercise. Among these, Zeo, a standout …
-
In recent years, the healthcare landscape has undergone a profound transformation, with a significant shift towards patient-centric care. Among the most promising innovations driving this change is the emergence of …
-
In Austria, there have been recent changes related to reimbursement coding for Medical procedures that make life easier for people interested in outpatient procedures. These changes are outlined in the Vereinbarungsumsetzungsgesetz …
-
The Danish Medicines Council recently unveiled its 2023 Annual Report, shedding light on the evolving landscape of Health Technology Assessment (HTA) in Denmark. This report not only provides valuable insights …
-
Companion diagnostics are in vitro diagnostic tests that help identify patients who are likely to benefit from a specific therapy based on their biomarkers or genetic variations. They are essential …
-
France has a comprehensive and dynamic reimbursement system for in vitro diagnostic tests, which covers a wide range of services, from laboratory tests to genetic tests to companion diagnostic tests. …